Why is the Mesoblast share price crashing 9% today?

1 day ago · The Mesoblast Ltd (ASX: MSB) share price is catching the eye of investors on Tuesday. Why are its shares being hammered?

9%
OFF

Why Is The Mesoblast Share Price Crashing 9% Today?

2 weeks from now

1 day ago · The Mesoblast Ltd (ASX: MSB) share price is catching the eye of investors on Tuesday. Why are its shares being hammered?

fool.com.au

9%
OFF

Why Is The Mesoblast Share Price Crashing 9% Today? - MSN

2 weeks from now

The Mesoblast Ltd (ASX: MSB) share price has returned from its trading halt and dropped into the red. At the time of writing, the biotech company's shares are down 9% to $2.55. The catalyst …

msn.com

18%
OFF

Why The Mesoblast Share Price Is Diving 18% After An FDA Win - MSN

2 weeks from now

Investors are sending the Mesoblast share price tumbling on Friday. But why? The post Why the Mesoblast share price is diving 18% after an FDA win appeared first on The Motley Fool …

msn.com

9%
OFF

Why Is The Mesoblast Share Price Crashing 9% Today?

2 weeks from now

The Mesoblast Ltd (ASX: MSB) share price has returned from its trading halt and dropped into the red. At the time of writing, the biotech company's shares are down 9% to $2.55.

webull.com.au

25%
OFF

Why Is The Mesoblast Share Price Sinking 25% On Tuesday?

2 weeks from now

Dec 5, 2023 · The Mesoblast Ltd (ASX: MSB) share price has returned from its trading halt with a bang. In morning trade, the biotechnology company's shares are down a massive 25% to a …

fool.com.au

7%
OFF

Why Brainchip, Fortescue, Mesoblast, And St George Mining …

2 weeks from now

Jan 7, 2025 · The Mesoblast share price is down 7% to $2.84. This may have been driven by profit taking from some investors after the biotechnology company's shares rocketed in 2024.

fool.com.au

18%
OFF

Why The Mesoblast Share Price Is Diving 18% After An FDA Win

2 weeks from now

Dec 20, 2024 · The Mesoblast Ltd (ASX: MSB) share price is taking a dive today. Here’s why the biotech stock is under pressure after yesterday’s FDA win.

fool.com.au

10%
OFF

Here’s Why The Mesoblast (ASX:MSB) Share Price Is Sinking - Rask …

2 weeks from now

Dec 15, 2020 · The Mesoblast Limited (ASX: MSB) share price has sunk around 10% after providing an update. Mesoblast is a business involved in allgeneic cellular medicines for …

raskmedia.com.au

4%
OFF

Here's Why The Mesoblast (ASX:MSB) Share Price Is Sinking Today

2 weeks from now

Jul 16, 2021 · The Mesoblast Limited (ASX: MSB) share price has sunk more than 4% in todays trading session after releasing an announcement earlier today.

fool.com.au

2%
OFF

Mesoblast (NASDAQ:MESO) Trading Down 2.2% - Here's Why

2 weeks from now

21 hours ago · Mesoblast Limited (NASDAQ:MESO - Get Free Report)'s stock price traded down 2.2% on Wednesday . The company traded as low as $16.53 and last traded at $16.61. …

marketbeat.com

77%
OFF

Up 77% In A Month! What's Going On With The Mesoblast Share …

2 weeks from now

Jan 7, 2025 · The Mesoblast Ltd (ASX: MSB) share price was one of the standout All Ordinaries stock performers in 2024. Here's why.

fool.com.au

$110
OFF

Here's Why The Mesoblast (ASX:MSB) Share Price Is Tumbling Lower …

2 weeks from now

Why is the Mesoblast share price tumbling lower today? Investors have been selling Mesoblast shares after it announced a US$110 million private placement led by a strategic US investor …

fool.com.au

11%
OFF

Why The Mesoblast (ASX:MSB) Share Price Is Sinking 11% Lower

2 weeks from now

Dec 14, 2020 · The Mesoblast limited (ASX: MSB) share price has come under pressure on Tuesday after the release of an announcement.

fool.com.au

FAQs about Why is the Mesoblast share price crashing 9% today? Coupon?

Why is the Mesoblast share price going nowhere?

The Mesoblast Ltd (ASX: MSB) share price is going nowhere after the company requested a trading halt this morning. Mesoblast requested that the trading halt remain in place ahead of an announcement about "a proposed financing". The company revealed no other details in its formal request. ...

Is Mesoblast a good stock to buy in 2024?

Mesoblast was the number one S&P/ASX All Ordinaries Index Â (ASX: XAO) share for price growth in 2024. The ASX biotech share rose by an astounding 900% to finish the year at $3.10 apiece on 31 December. Already in the new year, Mesoblast shares have hit a four-year high of $3.37. They closed at $2.81 apiece yesterday. ...

How much did Mesoblast raise?

This has seen the high-flying company raise a total of A$260 million (US$160 million) at a price of A$2.50 per new share. This represents a discount of 11% to where the Mesoblast share price last traded. Unfortunately for retail shareholders, they have been excluded from this capital raising. ...

Why is Mesoblast raising funds?

So much so, the price that Mesoblast is raising funds is a premium of 47% to where its shares were trading a month prior to Friday's trading halt. In addition, the company notes that the funds will be used to support clinical developments. ...

When did Mesoblast resubmit a request for FDA approval?

The FDA indicated Mesoblast finally had enough clinical data to support a resubmission for approval last March. The company resubmitted its request for approval in July. In anticipation of a positive result, more investors bought Mesoblast shares last year. This pushed the Mesoblast share price higher over the first half of 2024. ...

Does Mesoblast have a share purchase plan (SPP)?

This represents a discount of 11% to where the Mesoblast share price last traded. Unfortunately for retail shareholders, they have been excluded from this capital raising. The company has no plans to launch a share purchase plan (SPP) on this occasion. ...